Clinical trial
Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.
NCT00200694 · Nantes University Hospital, Other · Terminated
Key facts
| NCT number | NCT00200694 |
|---|---|
| Title | Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination. |
| Lead sponsor | Nantes University Hospital, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heavy Proteinuria |
| Intervention type | Drug |
| Interventions | ramipril 5 mg + valsartan 80 mg/day, ramipril 10 mg + valsartan 160 mg/day, ramipril 5 mg + valsartan 80 mg/day + increased dosage of furosémide. |
| Enrollment | 18 |
| Start date | Mar 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Feb 4, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: